| HOME >> BIOLOGY >> TECHNOLOGY |
Deferred tax assets, net 167,368 176,619
Other current assets 108,106 43,267
Total current assets 1,588,163 1,422,025
PROPERTY AND EQUIPMENT, net 501,575 500,396
GOODWILL 471,127 476,515
INTANGIBLE ASSETS, net 753,286 817,828
DEFERRED TAX ASSETS, net 171,865 141,752
OTHER ASSETS 169,589 147,753
$3,655,605 $3,506,269
CURRENT LIABILITIES:
Current portion of long-term debt $1,023,104 $1,237,169
Accounts payable 81,323 91,437
Accrued expenses 723,728 677,184
Total current liabilities 1,828,155 2,005,790
LONG-TERM DEBT 2,729 3,788
DEFERRED TAX LIABILITIES, net 72,088 56,540
OTHER LIABILITIES 180,539 138,084
Total liabilities 2,083,511 2,204,202
STOCKHOLDERS' EQUITY:
Common stock, $0.01 par value 713 700
Additional paid-in capital 2,050,035 1,934,965
Treasury stock, at cost (194,782) (158,173)
Accumulated deficit (413,166) (624,128)
Accumulated other comprehensive
income 129,294 148,703
Total stockholders' equity 1,572,094 1,302,067
$3,655,605 $3,506,269
'/>"/>
| SOURCE Cephalon, Inc. Copyright©2008 PR Newswire. All rights reserved |